Follow-The-Filings

Security · featured owners

IRD Opus Genetics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $5M
  • 1 add 1 exit

IRD (Opus Genetics Inc.) is held in 1 featured 13F book as of 2026 Q2. James Silverman - Opaleye Management is the largest tracked holder by portfolio weight (0.42%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman Add 0.42%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
James Silverman - Opaleye Management 2026 Q2 0.42% Add +0.4% 1,125,000 $5M History
Farallon Capital Management exited 2026 Q2 Last 2026 Q1 0.03% Exit −0.03% 1,000,000 $5M History

1 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 15 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
424B2 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.03 Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Sep 9, 2026 Filing Doc
4 Period Sep 3, 2026 Filing Doc
4 Period Sep 8, 2026 Filing Doc
4 Period Jul 23, 2026 · 4 forms Filing Doc
4 Period May 18, 2026 Filing Doc
4 Period Apr 23, 2026 · 6 forms Filing Doc
4 Period Apr 20, 2026 · 7 forms Filing Doc
4 Period Mar 16, 2026 · 4 forms Filing Doc

Updated 12 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $19.05M $10.99M $14.2M
Net income -$9.99M -$57.53M -$49.59M
Net margin * -52.4% -523.4% -349.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $53.95M $36.61M $50.04M
Total non-current assets * $0.00 $252,000 $199,000
Total assets $53.95M $36.86M $50.24M
Total current liabilities $4.04M $11.3M $7.78M
Total non-current liabilities * $0M $0M $27.11M
Total equity $49.91M $6.72M $15.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.11M -$25.58M -$35.25M
Cash from investing $0M $1.21M $0M
Cash from financing $8.98M $4.19M $50.02M
Net change in cash * $7.87M -$20.18M $14.77M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders